Why did Novo Nordisk sue Hims & Hers?

Novo Nordisk sued Hims & Hers for allegedly infringing patents related to its injectable weight-loss offerings.

What was the U.S. FDA's stance on Hims & Hers' weight-loss pill?

The U.S. FDA Commissioner warned that the offering and similar drugs were 'illegal copycats'.

How did Hims & Hers attempt to make their weight-loss pill work orally?

Hims & Hers planned to use a complex liposomal technology to aid in the absorption of the oral semaglutide, aiming to overcome the challenges of delicate peptide compounds.

Home / Business and Economy / Hims & Hers Pill Launch Fizzles Amidst Legal Battles

Hims & Hers Pill Launch Fizzles Amidst Legal Battles

19 Feb

•

Summary

Hims & Hers faced legal action from Novo Nordisk over its new weight-loss pill.
The U.S. FDA warned against Hims & Hers' offering as illegal copycats.
The company's stock price dropped significantly after the announcement.

Hims & Hers Pill Launch Fizzles Amidst Legal Battles

Hims & Hers Health's attempt to enter the lucrative weight-loss drug market with an affordable compounded oral semaglutide pill has encountered significant obstacles. The company announced plans to offer the pill for $49, a move that quickly drew criticism. The U.S. FDA Commissioner warned that such offerings were "illegal copycats."

Shortly after, Danish drugmaker Novo Nordisk initiated legal action against Hims & Hers, alleging patent infringement related to its injectable weight-loss treatments. This legal challenge stems from Novo Nordisk's patented technology crucial for oral semaglutide absorption, which Hims & Hers intended to replicate using complex liposomal technology.

Analysts suggest this oral GLP-1 could have opened a new market for Hims & Hers, targeting patients preferring pills to injections. However, the company has since retreated from its offering. The situation has impacted Hims & Hers' stock, which has fallen considerably since the announcement, raising questions about the company's long-term growth strategy as its established franchises mature.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.